UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(dD) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March ~~September 30~~31, ~~2021~~2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(dD) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission ~~File~~ ~~No.~~file number: 001-41004

MCLAREN TECHNOLOGY ACQUISITION CORP. ~~(Exact name of registrant as specified in its charter)~~

(Exact name of registrant as specified in its charter)

Delaware

86-2419708

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer

Identification No.)

2600 Michelson Drive, Suite 1700 Irvine, CA 92612 (Address of Principal Executive Offices, including zip code) (949) 989-4638 (Registrant’s telephone number, including area code) N/A (Former name, former address and former fiscal year, if changed since last report)

2600 Michelson Drive, Suite 1700

Irvine, CA

92612

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (949) 989-4638

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Title of Each Class:	Trading Symbol(s)	Name of Each Exchange on Which Registered:
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant	MLAIU	The Nasdaq Stock Market LLC
Class A common stock, par value $0.0001 per share	MLAI	The Nasdaq Stock Market LLC
Redeemable warrants, exercisable for Class A common stock at an exercise price of $11.50 per share	MLAIW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange ~~Act~~ Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ~~☐ No~~ ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See ~~the~~definition ~~definitions~~ of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐ Large accelerated filer ☐ Accelerated filer ☒☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): . Yes ☒ No ☐

As of ~~December~~May 1716, ~~2021,~~2022 there were 20,125,000 shares of ~~the~~ Class A ~~Common~~common ~~Stock~~stock, par value $0.0001 per share, and 5,031,250 shares of the Company’s Class B ~~Common~~common ~~Stock~~stock, par value $0.0001 per share, ~~of the Company~~ issued and outstanding.

MCLAREN TECHNOLOGY ACQUISITION CORP.

Table of Contents

		Page
Part I. Financial Information		1
Item 1.	Financial Statements	1
	Unaudited Condensed Balance Sheet as of September 30, 2021	1
	Condensed Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021	1
	Unaudited Condensed Statements of Operations for the three months ended September 30, 2021 and for the period from February 24, 2021 (inception) through September 30, 2021	2
	Condensed Statements of Operations for the three months ended March 31, 2022 and for the period February 24, 2021(Inception) through March 31, 2021 (Unaudited)	2
	Unaudited Condensed Statements of Changes in Stockholder’s Equity for the three months ended September 30, 2021 and for the period from February 24, 2021 (inception) through September 30, 2021	3
	Condensed Statements of Changes in Stockholder’s Equity (Deficit) for the three months ended March 31, 2022 and for the period February 24, 2021(Inception) through March 31, 2021 (Unaudited)	3
	Unaudited Condensed Statement of Cash Flows for the period from February 24, 2021 (inception) through September 30, 2021	4
	Condensed Statements of Cash Flows for the three months ended March 31, 2022 and for the period February 24, 2021(Inception) through March 31, 2021 (Unaudited)	4
	Notes to Unaudited Condensed Financial Statements	5
	Notes to Condensed Financial Statements (Unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1617
Item 3.	Quantitative and Qualitative Disclosures Regarding Market Risk	2021
Item 4.	Controls and Procedures	2021
Part II. Other Information		2122
Item 1.	Legal Proceedings	2122
Item 1A.	Risk Factors	2122
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2122
Item 3.	Defaults Upon Senior Securities	2122
Item 4.	Mine Safety Disclosures	2122
Item 5.	Other Information	22
Item 6.	Exhibits	2223

PART I. FINANCIAL INFORMATION

Item 1. Interim ~~Condensed~~ Financial Statements ~~(Unaudited)~~.

MCLAREN TECHNOLOGY ACQUISITION CORP.

CONDENSED BALANCE ~~SHEET~~SHEETS

SEPTEMBER 30, 2021

	March 31, 2022 (Unaudited)			December 31, 2021

Assets:
Cash	$	751,400		$	1,017,354
Prepaid expenses and other current assets		305,812			215,517
Total current assets		1,057,212			1,232,871
Prepaid expenses-non current		—			142,228
Cash and securities held in Trust Account		205,345,001			205,287,195
Total assets	$	206,402,213		$	206,662,294

Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit
Accrued expenses	$	172,529		$	205,076
Due to related party		10,000			10,000
Total current liabilities		182,529			215,076
Deferred underwriting fee		7,043,750			7,043,750
Total liabilities		7,226,279			7,258,826

Commitments and Contingencies (Note 6)
Common stock subject to possible redemption, 20,125,000 shares at redemption value of $10.20 at March 31, 2022 and December 31, 2021		205,275,000			205,275,000

Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—			—
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding, excluding 20,125,000 shares subject to possible redemption at March 31, 2022 and December 31, 2021		—			—
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,031,250 shares issued and outstanding at March 31, 2022 and December 31, 2021		503			503
Additional paid-in capital		—			—
Accumulated deficit		(6,099,569	)		(5,872,035	)
Total stockholders’ deficit		(6,099,066	)		(5,871,532	)
Total Liabilities, Common Stock Subject to Redemption and Stockholders’ Deficit	$	206,402,213		$	206,662,294

(UNAUDITED)

Assets:
Cash	$	25,000
Total current assets		25,000
Deferred offering costs		248,905
Total assets	$	273,905
Liabilities and Stockholder’s Equity
Accrued offering costs	$	6,054
Promissory note - related party		243,545
Total current liabilities		249,599
Commitments and Contingencies (Note 6)
Stockholder’s Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding		—
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,031,250 shares issued and outstanding(1)		503
Additional paid-in capital		24,497
Accumulated deficit		(694	)
Total stockholder’s equity		24,306
Total Liabilities and Stockholder’s Equity	$	273,905

(1) Includes up to 656,250 shares of Class B common stock subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5), after the Sponsor returned to the Company on June 23, 2021 and October 1, 2021, at no cost, an aggregate of 2,875,000 and 718,750 founder shares, respectively, which were cancelled, resulting in an aggregate of 5,031,250 founder shares outstanding. These financial statements have been retroactively adjusted to reflect the change in share capitalization (see Notes 5 and 8). As a result of the full exercise of the over-allotment option by the underwriters upon the consummation of the IPO, these shares are no longer subject to forfeiture (see Note 8).

The accompanying notes are an integral part of these unaudited condensed financial statements.

MCLAREN TECHNOLOGY ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the three months ended September 30, 2021			For the period from February 24, 2021 (inception) through September 30, 2021
	For the three months ended March 31, 2022			For the period from February 24, 2021 (Inception) through March 31, 2021
Formation cost	$	—		$	694
Formation costs	$	285,340		$	694
Net loss	$	—		$	(694	)
Loss from operations		(285,340	)		(694	)
Basic and diluted weighted average shares outstanding(1)	$	4,375,000		$	4,375,000
Other income
Basic and diluted net loss per common share	$	0.00		$	0.00
Interest earned on cash and securities held in Trust Account		57,806			-
Total other income		57,806			-
Net loss	$	(227,534	)	$	(694	)
Weighted average shares outstanding, common stock subject to possible redemption		20,125,000			-
Basic and diluted net loss per share, common stock subject to possible redemption	$	(0.01	)	$	-
Weighted average shares outstanding, Class B common stock		5,031,250			5,031,250
Basic and diluted net loss per share, Class B common stock	$	(0.01	)	$	(0.00	)

(1) Excludes up to 656,250 shares of Class B common stock subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5), after the Sponsor returned to the Company on June 23, 2021 and October 1, 2021, at no cost, an aggregate of 2,875,000 and 718,750 founder shares, respectively, which were cancelled, resulting in an aggregate of 5,031,250 founder shares outstanding. These financial statements have been retroactively adjusted to reflect the change in share capitalization (see Notes 5 and 8). As a result of the full exercise of the over-allotment option by the underwriters upon the consummation of the IPO, these shares are no longer subject to forfeiture (see Note 8).

The accompanying notes are an integral part of these unaudited condensed financial statements.

MCLAREN TECHNOLOGY ACQUISITION CORP.

CONDENSED ~~STATEMENTS~~ STATEMENTS OF CHANGES IN ~~STOCKHOLDER~~STOCKHOLDERS’S EQUITY (DEFICIT)

FOR THE THREE MONTHS ENDED ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 ~~AND FOR THE PERIOD FROM FEBRUARY 24, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021~~

(UNAUDITED)

	Class B				Additional					Total
	Common stock				Paid-in		Accumulated			~~Stockholder~~Stockholders’s
	Shares(1)		Amount		Capital		Deficit			Equity
	Shares		Amount		Capital		Deficit			Deficit
Balance as of February 24, 2021 (inception)		—	$	—	$	—	$	—		$	—
Balance as of December 31, 2021		5,031,250	$	503	$	—	$	(5,872,035	)	$	(5,871,532	)
Issuance of Class B common stock to Sponsor		5,031,250		503		24,497		—			25,000
Net loss		—		—		—		(227,534	)		(227,534	)
Net loss		—		—		—		(694	)		(694	)
Balance as of March 31, 2022		5,031,250	$	503	$	—	$	(6,099,569	)	$	(6,099,066	)
Balance as of June 30, 2021		5,031,250		503		24,497		(694	)		24,306
Net loss		—		—		—		—			—
Balance as of September 30, 2021		5,031,250	$	503	$	24,497	$	(694	)	$	24,306

~~(1)~~FOR ~~Includes~~THE upPERIOD toFROM FEBRUARY ~~656~~24,~~250~~ shares of Class B common stock subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5), after the Sponsor returned to the Company on June 23, 2021 and October 1, 2021, at no cost, an aggregate of 2,875,000 and 718,750 founder shares, respectively, which were cancelled, resulting in an aggregate of 5,031,250 founder shares outstanding. These financial statements have been retroactively adjusted to reflect the change in share capitalization (~~see Notes 5 and 8~~INCEPTION). AsTHROUGH aMARCH ~~result of the full exercise of the over-allotment option by the underwriters upon the consummation of the IPO~~31, ~~these shares are no longer subject to forfeiture (see Note 8).~~2021

(UNAUDITED)

	Class B				Additional					Total
	Common stock				Paid-in		Accumulated			Stockholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance as of February 24, 2021 (Inception)		—	$	—	$	—	$	—		$	—
Common stock issued to Sponsor		5,031,250		503		24,497		—			25,000
Net loss		—		—		—		(694	)		(694	)
Balance as of March 31, 2021		5,031,250	$	503	$	—	$	(694	)	$	24,306

The accompanying notes are an integral part of these unaudited condensed financial statements.

MCLAREN TECHNOLOGY ACQUISITION CORP.

CONDENSED ~~STATEMENT~~ STATEMENTS OF CASH FLOWS

FOR THE PERIOD FROM FEBRUARY 24, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021

(UNAUDITED)

Cash flows from operating activities:
	For the three months ended March 31, 2022			For the period from February 24, 2021 (Inception) through March 31, 2021
Net loss	$	(694	)
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Net loss	$	(227,534	)	$	(694	)
Formation costs paid by Sponsor in exchange for promissory note		694
Adjustments to reconcile net loss to net cash used in operating activities:
Net cash used in operating activities		—
Interest earned on cash and securities held in Trust Account		(57,806	)		—
Cash flows from financing activities:
Formation costs paid by Sponsor in exchange for promissory note		—			694
Proceeds from the sale of Class B shares to initial stockholder		25,000
Changes in operating assets and liabilities:
Net cash provided by financing activities		25,000
Prepaid expenses and other assets		51,933			—
Net change in cash		25,000
Accrued expenses		(32,547	)		—
Cash, beginning of the period		-
Net cash used in operating activities		(265,954	)		—
Cash, end of the period	$	25,000
Cash flows from financing activities:
Supplemental disclosure of non-cash financing activities:
Proceeds from sale of Class B common stock to Sponsor		—			25,000
Deferred offering costs included in accrued expenses	$	6,054
Net cash provided by financing activities		—			25,000
Deferred offering costs paid by Sponsor in exchange for promissory note	$	242,851
Net change in cash		(265,954	)		25,000
Cash, beginning of the period		1,017,354			—
Cash, end of the period	$	751,400		$	25,000
Supplemental non cash disclosure:
Deferred offering costs paid by Sponsor in exchange for promissory note - related party	$	—		$	61,806

The accompanying notes are an integral part of these unaudited condensed financial statements.

MCLAREN TECHNOLOGY ACQUISITION CORP.

NOTES TO ~~UNAUDITED~~ CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1 — Organization and Business Operations

McLaren Technology Acquisition Corp. (the “Company”) is a ~~newly organized~~ blank check company incorporated as a Delaware corporation on February 24, 2021. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target with respect to the Business Combination.

As of ~~September 30~~March 31, ~~2021~~2022, the Company had not commenced any operations. All activity for the period from February 24, 2021 (inception) through ~~September~~March 3031, 2022 ~~2021~~ relates to the Company’s formation, ~~and~~ the initial public offering (the “IPO”) described below and the search for a target company for the Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on its cash and ~~cash~~investments ~~equivalents~~ held in the trust account derived from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

The Company’s sponsor is McLaren Technology Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on November 2, 2021 (the “Effective Date”). On November 5, 2021, the Company consummated the IPO of 20,125,000 units (the “Units” and, with respect to the Class A common stock of the Company, par value $0.0001 per share, included in the Units being offered, the “public shares”) at $10.00 per Unit, including the full exercise of the underwriters’ over-allotment of 2,625,000 Units, generating gross proceeds to the Company of $201,250,000, which is discussed in Note 3.

Commencing December 23, 2021, holders of the 20,125,000 units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A common stock and warrants included in the units. Class A common stock and warrants that are separated will trade on the Nasdaq Stock Market LLC under the symbols “MLAI” and “MLAIW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “MLAIU.”

Simultaneously with the consummation of the IPO, the Company consummated the private placement of 9,050,000 Warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of $9,050,000, which is described in Note 4.

Additionally, simultaneously with the closing of the IPO, pursuant to a Subscription Agreement, dated November 2, 2021, by and between the Company and Mizuho Securities USA LLC, the representative of the underwriters (the “representative”), the Company completed the private sale of an aggregate of 300,000 shares of Class B common stock of the Company, par value $0.0001 per share (the “Representative Shares”) at a purchase price of approximately $3.33 per Representative Share, generating gross proceeds to the Company of $1,000,000. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Representative Shares was made pursuant to the exemption from registration contained in Section 4(~~see~~a)(2) ~~Notes~~of 5the ~~and~~Securities 6Act of 1933, as amended (the “Securities Act”) (see Note 5).

Transaction costs amounted to $13,436,005 consisting of $4,025,000 of underwriting commissions, $7,043,750 of deferred underwriting fees, $1,847,600 of, which represents the fair value of the Representative Shares in excess of cash paid ~~(see Note 6)~~, and $519,655 of other offering costs, and was all charged to stockholders’ deficit.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting commissions held in the Trust Account and taxes payable on the income earned on the Trust Account) at the time of the signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

~~Following~~The Company’s ~~the~~management ~~closing~~has ofbroad ~~the~~discretion ~~IPO~~with onrespect ~~November~~to 5,the ~~2021,~~specific ~~$205,275,000~~application ~~($10.20~~of ~~per Unit) from~~ the net proceeds of the ~~sale of Units in the~~ IPO and ~~a portion of the proceeds of the~~ sale of the Private Placement Warrants, ~~was~~although ~~deposited~~substantially ~~into~~all aof ~~trust account (“Trust Account”) located in~~ the ~~United~~net ~~States~~proceeds ~~with~~are ~~Continental~~intended ~~Stock~~to ~~Transfer~~be &applied ~~Trust~~generally ~~Company~~toward ~~acting~~consummating asa ~~trustee,~~Business ~~and will be invested only in U~~Combination.S. ~~government~~The ~~securities,~~Company’s ~~within~~Business ~~the~~Combination ~~meaning~~must ~~set~~be ~~forth~~with inone ~~Section~~or ~~2(a)(16)~~more oftarget ~~the~~businesses ~~Investment~~that ~~Company~~together ~~Act,~~have ~~having~~ a ~~maturity~~fair ~~of 185 days or less or in money~~ market ~~funds~~value ~~meeting~~equal ~~certain~~to ~~conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only~~at inleast 80% ~~direct~~of ~~U.S. government treasury obligations. Except with respect to interest earned on~~ the ~~funds~~net ~~held~~balance in the Trust Account ~~that~~(as ~~may be~~defined ~~released~~below) to(excluding the ~~Company~~amount ~~to pay its tax obligations and up to $100,000~~ of ~~interest~~deferred ~~that~~underwriting ~~may~~commissions ~~be used for its dissolution expenses, if any, the funds~~ held in the Trust Account ~~will~~and ~~not~~taxes bepayable ~~released~~on ~~from~~ the ~~Trust~~income ~~Account~~earned ~~until~~on the ~~earliest~~Trust ~~to occur of: (1~~Account) at the ~~Company’s completion~~time of ~~an initial Business Combination; (2)~~ the ~~redemption~~signing ~~of any public shares properly submitted in connection with~~ a ~~stockholder vote~~definitive toagreement ~~amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption~~ in connection with the ~~initial~~ Business Combination. orHowever, ~~to redeem 100% of~~ the ~~public shares if the~~ Company ~~does~~ ~~not~~will only complete ~~the~~a ~~initial~~ Business Combination ~~within~~if ~~15 months from~~ the ~~closing~~post-transaction ofcompany owns ~~the~~or ~~IPO~~acquires 50% (or upmore toof 24the ~~months~~outstanding ~~from~~voting ~~the~~securities ~~closing~~ of ~~the~~ ~~IPO if we extend~~ the ~~time~~target toor ~~complete~~otherwise acquires a ~~Business~~controlling ~~Combination~~interest ~~pursuant~~in to the ~~terms of the Company’s amended and restated certificate~~ oftarget ~~incorporation,~~business ~~the~~sufficient ~~“Combination~~for ~~Period”)~~it ornot ~~(B) with respect~~ to ~~any~~be ~~other~~required ~~provision relating~~ to ~~stockholders’~~register ~~rights or~~as ~~pre-initial~~an ~~Business~~investment ~~Combination~~company ~~activity;~~under ~~and (3)~~ the ~~redemption~~Investment ~~of the public shares if the~~ Company ~~has~~Act ~~not~~1940, ~~completed~~as ~~an initial~~amended ~~Business Combination within~~ (the ~~Combination~~“Investment ~~Period,~~Company ~~subject to applicable law~~Act”). ~~The~~There ~~proceeds~~is ~~deposited~~no inassurance that the ~~Trust~~Company ~~Account~~will ~~could~~be ~~become subject~~able to ~~the~~complete ~~claims~~a ofBusiness ~~the~~Combination ~~creditors, which would have priority over the claims of the Company’s public stockholders~~successfully.

~~The Company~~Following ~~will~~the ~~provide~~closing ~~its~~of ~~public~~the ~~stockholders~~IPO ~~with~~on November 5, 2021, $205,275,000 ($10.20 per Unit) from the ~~opportunity~~net toproceeds ~~redeem~~of ~~all~~the orsale of Units in the IPO and a portion of ~~their~~the ~~public~~proceeds ~~shares~~of ~~upon~~ the ~~completion~~sale of the ~~initial~~ ~~Business~~Private ~~Combination~~Placement ~~either~~Warrants was deposited into a trust account (1“Trust Account”) located in ~~connection~~the ~~with~~United aStates ~~stockholder~~with ~~meeting~~Continental ~~called~~Stock toTransfer ~~approve~~& ~~the~~Trust ~~initial~~Company ~~Business~~acting ~~Combination~~as ~~or (2)~~trustee, byand ~~means~~will ofbe ainvested ~~tender~~only ~~offer~~in U.S. government securities, ~~The~~within ~~decision~~the asmeaning toset ~~whether~~forth ~~the~~in ~~Company~~Section 2(a)(16) ~~will~~of ~~seek~~the ~~stockholder~~Investment ~~approval~~Company ofAct, having a ~~proposed~~maturity ~~Business~~of ~~Combination~~185 days or less or ~~conduct~~in amoney ~~tender~~market ~~offer~~funds ~~will~~meeting becertain ~~made~~conditions byunder Rule 2a-7 promulgated under the Investment Company, ~~solely~~Act inwhich ~~its~~invest only ~~discretion,~~in ~~and~~direct ~~will~~U.S. begovernment ~~based~~treasury onobligations. aExcept ~~variety~~with ofrespect ~~factors~~to ~~such~~interest asearned on the ~~timing~~ offunds held in the ~~transaction~~Trust ~~and~~Account ~~whether~~that may ~~the~~be ~~terms~~released ofto the ~~transaction~~Company ~~would~~to ~~require~~pay usits tax obligations and up to ~~seek~~$100,000 of ~~stockholder~~interest ~~approval~~that ~~under~~may ~~applicable~~be ~~law~~used for its dissolution expenses, orif ~~stock~~any, ~~exchange~~the ~~listing~~funds ~~requirement.~~held ~~The~~in ~~stockholders~~the ~~will~~Trust beAccount ~~entitled~~will tonot ~~redeem~~be ~~all~~released orfrom athe ~~portion~~Trust ofAccount until the ~~public~~earliest ~~shares~~to ~~upon~~occur of: (1) the ~~completion~~Company’s completion of ~~the~~an initial Business Combination; at(2) the aredemption ~~per-share~~of ~~price,~~any ~~payable~~public shares properly submitted in ~~cash,~~connection ~~equal~~with a stockholder vote to amend the ~~aggregate~~Company’s ~~amount~~amended ~~then~~and onrestated ~~deposit~~certificate inof incorporation (A) to modify the ~~Trust Account~~substance asor timing of ~~two~~the Company’s ~~business~~obligation ~~days~~to ~~prior~~allow toredemption ~~the~~in ~~consummation~~connection ofwith the initial Business Combination, ~~including~~or ~~interest~~to ~~earned~~redeem 100% onof the ~~funds~~public ~~held~~shares inif the ~~Trust~~Company ~~Account~~does ~~and~~ not ~~previously~~complete ~~released to~~ the ~~Company~~initial toBusiness ~~pay~~Combination ~~its~~within ~~taxes,~~15 ~~divided~~months byfrom the ~~number~~closing of the ~~outstanding~~IPO ~~public shares,~~(or ~~subject~~up to 24 months from the ~~limitations~~closing ~~described~~of ~~herein.~~the ~~The~~initial ~~amount~~public inoffering if we extend the ~~Trust~~time ~~Account~~to iscomplete ~~initially~~a ~~$10.20~~Business ~~per~~Combination ~~public~~pursuant ~~share.~~to ~~The~~the ~~per~~terms ~~share~~of the ~~amount~~Company’s amended and restated certificate of incorporation, the ~~Company~~“Combination ~~will~~Period”) ~~distribute~~or (B) with respect to ~~investors~~any other ~~who~~provision ~~properly~~relating ~~redeem~~to ~~their~~stockholders’ rights or pre-initial Business Combination activity; and (3) the redemption of the public shares ~~will~~if the Company has not becompleted ~~reduced~~an byinitial Business Combination within the ~~deferred~~Combination ~~underwriting~~Period, ~~commissions~~subject to applicable law. The proceeds deposited in the ~~Company~~Trust ~~will~~Account ~~pay~~could become subject to the ~~underwriters~~claims of the creditors, which would have priority than the claims of the Company’s public stockholders.

The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (1) in connection with a stockholder meeting called to approve the initial Business Combination or (2) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require us to seek stockholder approval under applicable law or stock exchange listing requirement. The stockholders will be entitled to redeem all or a portion of the public shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the company to pay its taxes, divided by the number of the outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is initially $10.20 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters.

The Company will have only the Combination Period to complete the initial Business Combination. However, if the Company has not completed the initial Business Combination within the Combination Period, the Company will (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (3) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor, directors and officers have entered into a letter agreement with the Company, pursuant to which they have agreed to waive: (1) their redemption rights with respect to any Founder Shares (defined below) and public shares held by them in connection with the completion of the initial Business Combination; (2) their redemption rights with respect to any Founder Shares and public shares held by them in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete its initial Business Combination within the Combination Period or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3) their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete its initial Business Combination within the Combination Period (4) vote any shares of Class B common stock held by them and any public shares purchased during or after the IPO in favor of the initial Business Combination.

The Sponsor, ~~has~~directors ~~agreed that it will be liable to the Company if~~ and toofficers ~~the~~have ~~extent~~entered ~~any~~into ~~claims by~~ a ~~third~~letter ~~party~~agreement ~~(other~~with ~~than~~ the Company’s, ~~independent auditors)~~pursuant ~~for~~to ~~services~~which ~~rendered~~they orhave ~~products~~agreed ~~sold~~ to ~~the~~waive: ~~Company,~~(1) their redemption orrights ~~a prospective target business~~ with ~~which~~respect ~~the~~to ~~Company~~any ~~has~~Founder ~~entered~~Shares ~~into a~~(defined ~~written~~below) ~~letter~~and ofpublic ~~intent,~~shares ~~confidentiality~~held orby ~~similar~~them ~~agreement~~in orconnection ~~Business~~with ~~Combination agreement, reduce~~ the ~~amount~~ completion of ~~funds in~~ the ~~Trust~~ ~~Account~~initial toBusiness ~~below~~Combination; ~~the lesser of~~ (12) their ~~$10.20~~redemption ~~per~~rights ~~public~~with ~~share~~respect orto ~~(2)~~any ~~the~~Founder ~~actual~~Shares ~~amount~~and ~~per~~public ~~share~~shares held by them in ~~the~~connection ~~Trust~~with ~~Account~~a asstockholder ofvote ~~the date~~to ofapprove ~~the~~an ~~liquidation~~amendment ofto the ~~Trust~~Company’s ~~Account~~amended ifand ~~less~~restated ~~than~~certificate ~~$10.20~~of ~~per share due~~ incorporation (A) to ~~reductions~~modify in the ~~value~~substance or timing of the ~~trust~~Company’s ~~assets,~~obligation ~~less~~to ~~taxes payable,~~allow ~~provided~~redemption ~~that~~in ~~such~~connection ~~liability~~with ~~will~~the ~~not~~initial ~~apply~~Business Combination ~~to any claims by a third party~~ or ~~prospective~~to ~~target~~redeem 100% ~~business who executed a waiver~~ of ~~any~~the ~~and~~public ~~all~~shares ~~rights~~if to the ~~monies~~Company ~~held~~does innot ~~the~~complete ~~Trust~~its ~~Account~~initial ~~(whether~~Business orCombination ~~not~~within ~~such~~the ~~waiver~~Combination Period isor ~~enforceable~~(B) with ~~nor~~respect ~~will it apply~~ to any ~~claims under~~other ~~the~~provision ~~Company’s~~relating ~~indemnity~~to ofstockholders’ ~~the~~rights ~~underwriters~~or ofpre- ~~the~~initial ~~IPO~~Business ~~against~~Combination ~~certain liabilities, including liabilities under the Securities~~activity; ~~Act~~and of(3) their ~~1933,~~rights asto ~~amended~~liquidating ~~(the~~distributions ~~“Securities~~from ~~Act”). However,~~ the ~~Company~~trust ~~has~~account ~~not~~with ~~asked~~respect ~~the Sponsor~~ to ~~reserve~~any ~~for~~Founder ~~such~~Shares ~~indemnification obligations,~~they ~~nor~~hold ~~has~~if the Company fail ~~independently verified whether the Sponsor has sufficient funds~~ to ~~satisfy~~complete its ~~indemnity~~initial ~~obligations and~~Business ~~the~~Combination ~~Company~~within ~~believes that~~ the ~~Sponsor’s~~Combination ~~only~~Period ~~assets~~(4) vote ~~are~~any ~~securities~~shares of ~~the~~Class ~~Company.~~B ~~Therefore,~~common ~~the~~stock ~~Company cannot assure that~~held ~~the~~by ~~Sponsor~~them ~~would~~and beany ~~able~~public toshares ~~satisfy~~purchased ~~those~~during ~~obligations.~~or ~~None~~after of the ~~Company’s~~IPO ~~officers~~in orfavor ~~directors~~of ~~will indemnify~~ the ~~Company~~initial ~~for claims~~Business ~~by third parties including, without limitation, claims by vendors and prospective target businesses~~Combination.

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the trust account to below the lesser of (1) $10.20 per public share or (2) the actual amount per share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.20 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

Liquidity and Capital Resources

~~As of September 30, 2021, the Company had $25,000 in cash and a working capital deficit of $224,599.~~ The Company’s liquidity needs up to ~~November~~its 5,IPO ~~2021~~ had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of up to $300,000 (see Note 5). The Company’s liquidity needs since its IPO and through March 31, 2022 have been satisfied through proceeds from the Private Placement. At March 31, 2022, the Company had $751,400 in its operating bank account and working capital of $874,683. The Company’s balance in the operating bank account mainly consisted of the portion of proceeds of the sale of the Private Placement Warrants not held in the Trust Account.

After consummation of the IPO on November 5, 2021, the Company had $2,025,000 in its operating bank account, and working capital of $1,183,964, which mainly consisted of the portion of proceeds of the sale of the Private Placement Warrants not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company ~~with~~ Working Capital Loans, as defined below (see Note 5). As of ~~November~~March 1731, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Going Concern

In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution described earlier in Note 1, should the Company be unable to complete a business combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company has until February 5, 2023, 15 months from the closing of the IPO, to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by the specified period. If a Business Combination is not consummated by February 5, 2023, there will be a mandatory liquidation and subsequent dissolution. These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The Company intends to complete a business combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate any business combination by February 5, 2023.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic and Russia-Ukraine war and has concluded that while it is reasonably possible that the virus and war could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of ~~the~~these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s ~~final~~Form ~~prospectus~~10-K ~~dated November 2, 2021, which contains the initial audited financial statements and notes thereto~~ for the period ~~from~~ended ~~February 24~~December 31, 2021 ~~(inception) to March 15, 2021,~~ as filed with the SEC on ~~November~~April 315, ~~2021~~2022, ~~and the Company’s report on Form 8-K,~~ which contains the ~~Company’s~~ audited ~~balance~~financial ~~sheet~~statements and notes ~~thereto~~ ~~as of November 5, 2021, as filed with the SEC on November 15, 2021~~thereto. The interim results for the three months ended ~~September~~March 3031, ~~2021~~ ~~and~~2022 ~~for the period from February 24, 2021 (inception) through September 30, 2021~~ are not necessarily indicative of the results to be expected for the year ending December 31, 2022 ~~2021~~ or for any future interim periods.

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart ~~our~~Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and ~~stockholder~~ approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.8

Further, Section102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company held no cash equivalents as of March 31, 2022. The Company ~~did~~held ~~not~~U.S. ~~have~~Treasury ~~any~~Bills with a maturity of less than three months in the amount of $205,274,080 which it considers as cash equivalents as of ~~September~~December 3031, 2021.

~~Deferred~~Cash and ~~Offering~~Securities ~~Costs~~Held in Trust Account

~~The~~As ~~Company~~of March ~~complies~~31, ~~with~~2022, ~~the~~investment ~~requirements~~in of the ~~ASC~~Company’s ~~340-10-S99-1.~~Trust ~~Deferred~~Account ~~offering~~consisted ~~costs consists~~ of ~~legal~~$28,489 cash ~~accounting~~and $205,316,512 ~~underwriting~~in ~~fees~~U.S. ~~and~~Treasury ~~other~~Securities. ~~costs~~As ~~incurred~~of ~~through~~December ~~the~~31, ~~balance~~2021, ~~sheet~~investment ~~date~~in ~~that~~the ~~are~~Company’s ~~directly~~Trust ~~related~~Account toconsisted ~~the~~of ~~IPO.~~$13,115 cash ~~Offering~~and ~~costs~~$205,274,080 in ~~are~~U.S. Treasury ~~allocated~~Securities. toAll of the ~~separable~~U.S. ~~financial instruments~~Treasury toSecurities beheld ~~issued~~at inMarch ~~the~~31, ~~IPO~~2022 ~~based~~which onwere apurchased ~~relative~~on ~~fair~~March ~~value basis~~10, ~~compared~~2022 towill ~~total~~mature ~~proceeds~~on June 21, ~~received~~2022. ~~Upon~~The ~~closing~~Company ofearned ~~the~~interest ~~IPO on~~of ~~November 5~~$57,806 ~~2021,~~for ~~offering~~the ~~costs~~three ~~associated~~months ~~with~~ended ~~the~~March ~~Class~~31, A2022. ~~common~~The ~~stock~~Company ~~and~~did ~~the~~not ~~warrants~~withdraw ~~were~~any ~~charged~~of tothe ~~stockholders’ equity.~~interest ~~Transaction~~income ~~costs~~from ~~amounted~~the toTrust ~~$13,436,005,~~Account ~~all~~to ofpay ~~which~~its ~~was~~tax ~~allocated to stockholders’ deficit~~obligations.

8The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.

A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying cost to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry in which the investee operates.

Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion are included in the “interest income” line item in the statements of operations. Interest income is recognized when earned. The carrying value, excluding gross unrealized holding gains, and fair value of held to maturity securities at March 31, 2022 and December 31, 2021 are as follows:

	Carrying Value as of March 31, 2022		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value as of March 31, 2022
U.S. Treasury Securities	$	205,316,512	$	—	$	(34,342	)	$	205,282,170
Cash		28,489		—		—			28,489
	$	205,345,001	$	—	$	(34,342	)	$	205,310,659

	Carrying Value as of December 31, 2021		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value as of December 31, 2021
U.S. Treasury Securities	$	205,274,080	$	920	$	—	$	205,275,000
Cash		13,115		—		—		13,115
	$	205,287,195	$	920	$	—	$	205,288,115

Common Stock Subject to Possible Redemption

All of the 20,125,000 public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with the SEC and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, at March 31, 2022 and December 31, 2021, all shares of common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s financial statements.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

The Class A common stock subject to possible redemption reflected on the balance sheets as of March 31, 2022 and December 31, 2021 is reconciled in the following table:

Gross Proceeds from IPO	$	210,250,000
Proceeds allocated to Public Warrants		(4,628,750	)
Class A common stock issuance costs		(13,147,623	)
Accretion of carrying value to redemption value		21,801,373
Class A common stock subject to possible redemption	$	205,275,000

Offering Costs associated with the Initial Public Offering

The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that were directly related to the IPO. Offering costs amounted to $13,436,005 and were charged to temporary equity upon the completion of the IPO.

Fair Value of Financial Instruments

The Company applies ASC Topic 820, Fair Value Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

The carrying amounts reflected in the balance ~~sheet~~sheets for current assets and current liabilities approximate fair value due to their short-term nature.

Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, all shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ~~the Financial Accounting Standards board (“FASB”)~~ ASC Topic 815, “Derivatives and Hedging” ~~(“ASC 815”)~~. Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance ~~sheet~~sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

9Income Taxes

The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits or uncertain tax positions as of March 31, 2022 and December 31, 2021, and, as such, no amounts accrued for interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock ~~shares~~ and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for its outstanding warrants as equity-classified instruments.

Net Loss Per Common Share

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 656,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriter. At September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the periods presented.

Income Taxes

The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction.

The Company is subject to income tax examinations by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be immaterial for the three months ended September 30, 2021 and for the period from February 24, 2021 (inception) through September 30, 2021.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to ~~concentration~~concentrations of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal ~~depository~~ ~~insurance~~Depository ~~coverage~~Insurance Coverage of $250,000. AsAt ofMarch ~~September~~31, 302022 and December 31, 2021, the Company had not experienced losses on this account and management believes the Company was not exposed to significant risks on such account.

Net Loss Per Common Share

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. At March 31, 2022 and December 31, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per share of common stock is the same as basic net loss per share of common stock for the period presented.

	For the three months ended March 31, 2022						For the period from February 24, 2021 (Inception) through March 31, 2021
	Class A			Class B			Class A		Class B
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(182,027	)	$	(45,507	)	$	-	$	(694	)

Denominator:
Weighted-average shares outstanding including common stock subject to redemption		20,125,000			5,031,250			-		5,031,250
Basic and diluted net loss per share	$	(0.01	)	$	(0.01	)	$	-	$	(0.00	)

Recent Accounting Pronouncements

InThe ~~August 2020, the FASB issued ASU No. 2020-06, “Debt with Conversion and Other Options” (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity~~Company’s ~~Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments.~~ ~~The~~management ~~guidance~~does ~~removes~~not ~~certain~~believe ~~accounting models~~ that ~~separate~~any ~~the~~recently ~~embedded~~issued, ~~conversion~~but ~~features~~not ~~from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is~~ effective, ~~for~~accounting ~~fiscal~~standards, ~~years~~if ~~beginning~~currently ~~after December 15~~adopted, ~~2021,~~would ~~and~~have ~~interim~~a ~~periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the~~material ~~impact~~effect ~~this change will have~~ on ~~its~~the accompanying financial statements.

~~Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.~~12

Note 3 — Initial Public Offering

On November 5, 2021, the Company sold 20,125,000 Units, including the full exercise of the underwriters’ over-allotment option to purchase 2,625,000 Units, at a purchase price of $10.00 per Unit. Each Unit ~~consists~~consisted of one share of Class A common stock, an aggregate of 20,125,000 shares, and one-half of one redeemable public warrant, an aggregate of 10,062,500 public warrants. Each whole public warrant will entitle the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share, subject to adjustment (see Note 7).

Note 4 — Private Placement

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 9,050,000 Private Placement Warrants at a price of $1.00 per warrant in a private placement, for an aggregate purchase price of $9,050,000. Each whole private placement warrant will entitle the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share, subject to adjustment.

The Private Placement Warrants may not be transferred, assigned or sold until 30 days after the consummation of an initial Business Combination, and will not be redeemable by the Company. The initial purchasers, or their permitted transferees, have the option to exercise the Private Placement Warrants on a cashless basis. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the warrants sold as part of the Units in the IPO.

Note 5 — Related Party Transactions

Founder Shares

On March 9, 2021, the Sponsor purchased 8,625,000 shares of Class B common stock, par value $0.0001 (the “Founder Shares”), for an aggregate purchase price of $25,000, or approximately $0.003 per share. On June 23, 2021, the Sponsor returned to the Company, at no cost, an aggregate of 2,875,000 Founder Shares, which the Company cancelled. On October 1, 2021, the Sponsor returned to the Company, at no cost, an aggregate of 718,750 Founder Shares, which the Company cancelled, resulting in an aggregate of 5,031,250 Founder Shares outstanding and held by the Sponsor, or approximately $0.005 per share ~~(see Note 8)~~. ~~The accompanying financial statements have been retroactively adjusted to reflect these cancellations in the share capitalization.~~ Up to 656,250 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. As a result of the full exercise of the over-allotment option by the underwriters upon the consummation of the IPO, these shares are no longer subject to forfeiture ~~(see Note 8)~~.

11On November 5, 2021, the Sponsor forfeited and returned, and the Company then cancelled, 300,000 Founder Shares at no cost, and the representative purchased 300,000 shares of Class B common stock, for an aggregate purchase price of $1,000,000, in connection with the closing of the IPO. Additionally, on November 5, the Sponsor transferred 50,000 Founder Shares to the representative as additional compensation for underwriting the IPO (see Note 6).

On November 5, 2021, the Sponsor cancelled 300,000 Founder Shares at no cost, and the representative purchased 300,000 shares of Class B common stock, for an aggregate purchase price of $1,000,000, in connection with the closing of the IPO. Additionally, on November 5, the Sponsor transferred 50,000 Founder Shares to the representative as additional compensation for underwriting the IPO (see Notes 6 and 8).

The initial stockholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of its stockholders having the right to exchange their Class A common stock for cash, securities or other property (the “lock-up”). Notwithstanding the foregoing, if the closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lock-up.

Promissory Note — Related Party

On ~~March~~ March 1, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. This loan is was non-interest bearing, unsecured and is due at the earlier of December 31, 2021 or the closing of the IPO. As of ~~September~~March 3031, 2022 and December 31, 2021, the Company had ~~borrowed~~no ~~$243,545~~outstanding ~~under~~borrowings on the promissory note~~, which is currently due upon demand~~.

Working Capital Loans

In addition, in order to fund working capital deficiencies or finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest bearing basis (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants ~~would~~ would be identical to the Private Placement Warrants. Except as set forth above, the terms of the Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of ~~September~~March 3031, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.

Administrative Support Fee

~~The~~Commencing on ~~Company~~the ~~entered~~date ~~into an~~that ~~administrative~~our ~~support~~securities ~~agreement~~were onfirst ~~November~~listed 2,on ~~2021,~~the ~~pursuant~~Nasdaq toGlobal ~~which~~Market, the Company ~~will~~agreed to pay an affiliate of the Sponsor, $10,000 per month for office space, utilities and secretarial and administrative support services. Upon completion of the initial Business Combination or ~~the Company’s~~our liquidation, ~~the~~we ~~Company~~ will cease paying these monthly fees. The Company incurred $30,000 in administrative support service expense for the three months ended March 31, 2022. At March 31, 2022 and December 31, 2021, a total of $10,000 was accrued for amounts owed by the Company to the Sponsor under the administrative support agreement.

Note 6 — Commitments and Contingencies

Registration Rights

The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants, which were issued in a private placement simultaneously with the closing of the IPO (and the shares of Class A common stock underlying such Private Placement Warrants) and (iii) warrants that may be issued upon conversion of Working Capital Loans ~~will~~ have registration rights that to require the Company to register a sale of any of the Company’s securities held by them pursuant to a registration rights agreement which towas be signed ~~prior to or~~ on ~~the~~November ~~effective~~5, ~~date of the IPO~~2021. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

On November 5, 2021, the Company paid a cash underwriting discount of 2.0% per Unit, or $4,025,000.

Additionally, the underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO, or $7,043,750, upon the completion of the Company’s initial Business Combination.

Representative’s Common Stock

On November 5, 2021, the Sponsor ~~cancelled~~forfeited and returned, and the Company then cancelled 300,000 Founder Shares at no cost, and the representative purchased 300,000 Class B shares, for an aggregate purchase price of $1,000,000. The Company estimated the fair value of these 300,000 Class B shares to be $2,440,800, and has recorded the $1,440,800 excess of fair value of the shares above the cash paid as an offering cost, which was recorded as a charge to stockholders’ ~~equity~~deficit. Additionally, on November 5, 2021, the Sponsor transferred 50,000 Founder Shares to the representative for no cost. The Company estimated the fair value of these shares to be $406,800 which was recorded as an offering cost and charged to stockholders’ deficit.

The representative will be subject to the same restrictions and other agreements of the Sponsor with respect to the Founder Shares. The Founder Shares transferred to the representative will be subject to the same concessions as those applied to the Founder Shares held by the sponsor in accordance with the terms of a Business Combination.14

~~Note~~The 7representative will —be ~~Stockholder’s~~subject ~~Equity~~to the same restrictions and other agreements of the Sponsor with respect to the Founder Shares. The Founder Shares transferred to the representative will be subject to the same concessions as those applied to the Founder Shares held by the Sponsor in accordance with the terms of a Business Combination.

~~Preferred~~Note 7 ~~Stock~~ — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the CompanyStockholders’s ~~board of directors. At September 30, 2021, there were no shares of preferred stock issued or outstanding.~~Deficit

~~Class A Common stock~~ Preferred Stock — The Company is authorized to issue ~~100~~ 1,000,000 shares of ~~Class~~preferred ~~A common~~ stock with a par value of $0.0001 and with ~~per~~such ~~share~~designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At ~~September~~March 3031, 2022 and December 31, 2021, there were no shares of ~~Class~~preferred ~~A common~~ stock issued ~~and~~or outstanding.

Class A B Common stock — The Company is authorized to issue 10 100,000,000 shares of Class BA common stock with a par value of $0.0001 per share. At ~~September~~March 3031, 2022 and December 31, 2021, there were ~~5,031,250~~no shares of Class BA common stock issued and outstanding (excluding 20,125,000 shares subject to possible redemption).

Class B Common stock — The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. At March 31, 2022 and December 31, 2021, there were 5,031,250 shares of Class B common stock issued and outstanding.

Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as required by law. Unless specified in the Company’s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporate Law or applicable stock exchange rules, the affirmative vote of a majority of the Company’s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.

The Class B common stock will automatically convert into Class A common stock upon the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of Class A common stock outstanding after such conversion, including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding (i) any shares of Class A common stock redeemed by public stockholders in connection with the initial Business Combination and (ii) any Class A common stock or equity-linked securities exercisable for or convertible into Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any ~~wa840020..rrants~~warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

13Warrants – The Company accounts for the 19,112,500 warrants, issued and outstanding at March 31, 2022 and December 31, 2021, in connection with the IPO (10,062,500 Public Warrants and 9,050,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. The Company concluded that the Public and Private Placement Warrants are considered indexed to the entity’s own stock and meet other equity classification requirements. Therefore, Public and Private Placement Warrants are considered equity instruments and are classified as such.

Warrants – As of September 30, 2021, there were no warrants issued or outstanding. Upon consummation of the IPO on November 5, 2021, 10,062,500 public warrants and 9,050,000 Private Placement Warrants were issued and are currently outstanding. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance), (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.15

Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance), (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The warrants will become exercisable on the later of 12 months from the closing of the IPO or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

●

In whole and not in part;

●

at a price of $0.01 per warrant;

●

upon a minimum of 30 days’ prior written notice of redemption given after the warrants become exercisable (the “30-day redemption period”) to each warrant holder; and

●

if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.

The Private Placement Warrants may not be transferred, assigned or sold, except to permitted transferees, until 30 days after the consummation of an initial Business Combination, and will not be redeemable by the Company. The initial purchasers, or their permitted transferees, have the option to exercise the Private Placement Warrants on a cashless basis. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the warrants ~~being~~ sold as part of the units in the IPO.

The Company accounts for the 19,112,500 warrants issued in connection with the IPO (10,062,500 Public Warrants and 9,050,000 Private Placement Warrants in accordance with the guidance contained in ASC 815-40). The Company concluded that the Public and Private Placement Warrants are considered indexed to the entity’s own stock and meet other equity classification requirements. Therefore, Public and Private Placement Warrants are considered equity instruments and are classified as such.

Note 8 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the ~~financial~~unaudited condensed financial statements were issued. ~~Except~~The ~~as disclosed in the footnotes elsewhere and below, the~~ Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

On October 1, 2021, the Sponsor returned to the Company, at no cost, an aggregate of 718,750 Founder Shares, which the Company cancelled, resulting in an aggregate of 5,031,250 Founder Shares outstanding and held by the Sponsor. The accompanying financial statements have been retroactively adjusted to reflect such cancellation in the share capitalization.16

OnITEM ~~November 5, 2021, the Company consummated its IPO of 20,125,000 Units, including~~ 2~~,625,000~~. ~~Units issued pursuant to the full exercise of the underwriters~~MANAGEMENT’ ~~over-allotment~~S ~~option.~~DISCUSSION ~~The~~AND ~~Units~~ANALYSIS ~~were~~OF ~~sold~~FINANCIAL atCONDITION aAND ~~price~~RESULTS ofOF $10.00 per Unit, generating gross proceeds to the Company of $201,250,000. Simultaneously with the consummation of the IPO, pursuant to a Private Placement Warrants Purchase Agreement with the Sponsor, the Company completed the private sale of an aggregate of 9,050,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $9,050,000. Simultaneously with the consummation of the IPO, (i) the Sponsor cancelled 300,000 Founder Shares at no cost and (ii) pursuant to a Subscription Agreement with Mizuho Securities USA LLC, the Company completed the private sale of an aggregate of 300,000 Representative Shares at a purchase price of approximately $3.33 per Representative Share, generating gross proceeds to the Company of $1,000,000.OPERATIONS

~~Additionally,~~References onin ~~November~~this 5,report (the ~~Sponsor~~“Quarterly ~~transferred~~Report”) 50to the “Company,~~000~~” ~~Founder~~“us,” ~~Shares~~“our” or “we” refer to ~~the~~McLaren ~~representative~~Technology asAcquisition ~~additional~~Corp. ~~compensation~~The ~~for~~following ~~underwriting~~discussion ~~the~~and ~~IPO.~~analysis of our financial condition and results of operations ~~See~~should ~~Note~~be 5,read ~~“Related~~in ~~Party~~conjunction ~~Transactions”~~with our unaudited condensed financial statements and ~~Note~~related notes 6,thereto ~~“Stockholders~~contained ~~Equity,”~~elsewhere ~~for~~in ~~further~~this ~~detail~~Quarterly Report.

~~The~~Cautionary ~~Company~~Note ~~entered into an administrative support agreement on November 2, 2021, pursuant to which the Company will pay an affiliate~~Regarding ofForward-Looking the Sponsor, $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. Statements

15All statements other than statements of historical fact included in this Report including, without limitation, statements under this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward- looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those contemplated by the forward- looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

~~Item~~The following 2.discussion ~~Management’s~~and ~~Discussion~~analysis of our financial condition and ~~Analysis~~results of ~~Financial~~operations ~~Condition~~should be read in conjunction with the unaudited condensed financial statements and ~~Results~~the ofnotes ~~Operations~~thereto contained elsewhere in this Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

References to the “Company,” “McLaren Technology Acquisition Corp.,” “our,” “us” or “we” refer to McLaren Technology Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.Overview

~~Cautionary~~We are ~~Note~~a ~~Regarding~~blank ~~Forward-Looking~~check ~~Statements~~company incorporated on February 24, 2021, as a Delaware corporation and formed for the purpose of effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

~~This Quarterly Report on~~We ~~Form~~expect ~~10-Q~~to ~~includes~~continue ~~forward-looking~~to ~~statements~~incur ~~within~~significant ~~the~~costs ~~meaning~~in ~~of Section 27A of~~ the ~~Securities~~pursuit ~~Act and Section 21E~~ of ~~the Exchange Act. We have based these forward-looking statements on~~ our ~~current~~acquisition ~~expectations and projections about future events~~plans. ~~These~~We ~~forward-looking statements~~cannot ~~are~~assure ~~subject~~you ~~to known and unknown risks, uncertainties and assumptions about us~~ that ~~may cause~~ our ~~actual~~plans ~~results,~~to ~~levels of~~complete ~~activity,~~an ~~performance~~initial orbusiness ~~achievements~~combination towill be ~~materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements~~successful. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

~~Overview~~Results of Operations

WeAs of ~~are~~March a31, ~~newly~~2022, ~~organized blank~~we ~~check~~had ~~company~~not ~~incorporated~~commenced onany operations. All activity for the period from February 24, 2021 as(inception) athrough ~~Delaware~~March ~~corporation~~31, 2022 ~~and~~relates ~~formed~~to ~~for~~our formation, the ~~purpose~~initial ofpublic ~~effect~~offering and the search for a ~~merger,~~target ~~capital~~company for an initial business combination. We ~~stock~~have ~~exchange,~~neither ~~asset~~engaged ~~acquisition,~~in ~~stock~~any ~~purchase,~~operations ~~reorganization~~nor orgenerated ~~similar~~any revenues to date. We will not generate any operating revenues until after the completion of our initial business combination, ~~with~~at ~~one~~the orearliest. ~~more~~We ~~businesses~~will (generate non-operating income in the ~~“Business~~form of interest income ~~Combination”~~on cash and cash equivalents from the proceeds derived from the initial public offering. We incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

~~Our sponsor is McLaren Technology~~For ~~Acquisition Sponsor LLC, a Delaware limited liability company (~~the ~~“Sponsor”).~~three ~~The~~months ~~registration~~ended ~~statement~~March ~~for our initial public offering was declared effective on November 2~~31, ~~2021. On November 5~~2022, ~~2021,~~ we ~~consummated~~had ~~our initial public offering (the “IPO”) of 20,125,000 Units, including the full exercise of the underwriters’ over-allotment option to purchase 2,625,000 Units, at~~ a ~~purchase~~net ~~price~~loss of $~~10.00 per Unit. Transaction costs amounted to $13~~227,~~436~~534,~~005~~ ~~consisting~~which ofconsisted ~~$4,025,000~~ of ~~underwriting~~formation ~~commissions,~~costs ~~$7,043,750~~ of ~~deferred underwriting commissions,~~ $1285,~~847,600~~340 ofoffset ~~fair~~by ~~value of the Representative Shares in~~interest ~~excess~~income of ~~cash paid, and~~ $~~519~~57,~~655 of other offering costs, and was all charged to stockholders’ deficit~~806.

~~Simultaneously with the consummation~~For of the ~~IPO,~~period wefrom ~~consummated~~February ~~the private placement of 9~~24,~~050,000~~ ~~warrants~~2021 (~~the “Private Placement Warrants”~~inception) tothrough ~~the~~March ~~Sponsor~~31, at a2021, ~~price~~we ofhad ~~$1.00~~a ~~per~~net ~~Private~~loss ~~Placement~~of ~~Warrant~~$694, ~~generating~~which ~~gross~~consisted ~~proceeds to us~~ of ~~$9,050,000~~formation costs.

~~Upon~~Liquidity ~~the closing of the IPO~~ and ~~the Private Placement, an amount of $205,275,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the~~Capital sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to us to pay our tax obligations and up to $100,000 of interest that may be used for our dissolution expenses, the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (a) the completion of the initial Business Combination, (b) the redemption of any public shares properly submitted in connection with a stockholder vote to amend our certificate of incorporation (i) to modify the substance or timing of our obligation to allow redemption in connection with the initial Business Combination or certain amendments to our charter prior thereto or to redeem 100% of the public shares if we does not complete our initial Business Combination within the Combination Period or (ii) with respect to any other provision relating to stockholders’ rights or pre-Business Combination activity, and (c) the redemption of the public shares if we are unable to complete our initial Business Combination within the Combination Period, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of our creditors, if any, which could have priority over the claims of our public stockholders. Resources

16On November 5, 2021, we consummated our initial public offering of 20,125,000 units, including the full exercise of the underwriters’ over-allotment option to purchase 2,625,000 units, at a purchase price of $10.00 per unit. Transaction costs amounted to $13,436,005 consisting of $4,025,000 of underwriting commissions, $7,043,750 of deferred underwriting commissions, $1,847,600, which represents the fair value of the representative shares in excess of cash paid, and $519,655 of other offering costs, and was all charged to stockholders’ deficit.

We will have only until the Combination Period to complete the initial Business Combination. However, if we are unable to complete the initial Business Combination within the Combination Period (and our stockholders have not approved an amendment to our charter extending this time period), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.17

~~Liquidity~~Simultaneously with ~~and~~the ~~Capital~~consummation ~~Resources~~of the initial public offering, we consummated the private placement of 9,050,000 placement warrants to the sponsor, at a price of $1.00 per placement warrant, generating gross proceeds to us of $9,050,000.

AsUpon the closing of ~~September~~the ~~30,~~initial ~~2021~~public offering and the private placement, we ~~had~~an amount of $25205,275,000 in($10.20 ~~cash~~per ~~and~~unit) afrom ~~working~~the ~~capital~~net ~~deficit~~proceeds of the sale of ~~$224,599~~the ~~(excluding~~units ~~deferred~~in the initial public offering ~~costs)~~and the sale of the private placement warrants was deposited into a trust account.

Our liquidity needs up to ~~September~~November 305, 2021 had been satisfied through a ~~capital~~payment ~~contribution~~ from ~~our~~the ~~Sponsor~~sponsor of $25,000 (see Note 5) for the ~~Founder~~founder ~~Shares~~shares to cover certain offering costs and the loan under an unsecured promissory note from ~~our~~the ~~Sponsor~~sponsor of up to $300,000. ~~After~~(see ~~consummation~~Note ~~of the IPO on November~~ 5,). ~~2021, we~~Since ~~had approximately $2 million in~~ our ~~operating~~initial ~~bank~~public ~~account,~~offering ~~and~~through ~~working~~March ~~capital of approximately $1.2 million. In addition~~31, ~~in order to finance transaction costs in connection with a Business Combination~~2022, our ~~Sponsor~~liquidity orneeds ~~an affiliate of the Sponsor or certain of our officers and directors may, but are not obligated to, provide us with Working Capital Loans. As of November 17, 2021, there~~ were nosatisfied ~~amounts~~through ~~outstanding~~funds ~~under~~from ~~any~~the ~~Working~~private ~~Capital~~placement ~~Loans~~warrants.

~~Based~~At March on31, ~~the~~2022 ~~foregoing,~~and ~~management believes~~December ~~that~~31, 2021, we ~~will~~had ~~have~~$751,400 ~~sufficient~~and $1,017,354, respectively, in the operating bank account and working capital of to$874,683 ~~meet~~and ~~our~~$1,017,795, ~~needs~~respectively, ~~through~~which mainly consisted of the ~~earlier~~portion of proceeds of the ~~consummation~~sale of athe ~~Business~~private ~~Combination~~placement warrants ornot ~~one~~held ~~year~~in ~~from~~the ~~this~~trust ~~filing~~account. ~~Over~~In ~~this time period~~addition, wein ~~will~~order beto ~~using~~finance ~~these~~transaction ~~funds~~costs ~~for~~in ~~paying~~connection ~~existing~~with ~~accounts~~an ~~payable,~~initial ~~identifying~~business ~~and~~combination, ~~evaluating~~our ~~prospective~~sponsor ~~initial~~or ~~Business~~an ~~Combination~~affiliate ~~candidates,~~of ~~performing~~the ~~due~~sponsor ~~diligence~~or oncertain ~~prospective~~of ~~target~~our ~~businesses,~~officers ~~paying~~and ~~for travel~~directors ~~expenditures~~may, ~~selecting~~but ~~the~~are ~~target~~not ~~business~~obligated to, ~~merge~~provide us with orworking capital ~~acquire~~loans. As of March 31, 2022 and ~~structuring~~December 31, ~~negotiating~~2021, ~~and~~there ~~consummating~~were ~~the~~no ~~Business Combination~~amounts outstanding under any working capital loans.

~~Risks~~Based on the foregoing, management believes that we will have sufficient working capital to meet our needs through the earlier of the consummation of an initial business combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and ~~Uncertainties~~evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the initial business combination.

~~Management~~Going continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of our operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.Concern

~~Results~~In connection with our assessment of ~~Operations~~going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution described in Note 1, should we be unable to complete an initial business combination, raises substantial doubt about our ability to continue as a going concern. We have until February 5, 2023, 15 months from the closing of the initial public offering, to consummate an initial business combination. It is uncertain that we will be able to consummate an initial business combination by the specified period. If an initial business combination is not consummated by February 5, 2023, there will be a mandatory liquidation and subsequent dissolution. The accompanying unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern. We intend to complete an initial business combination before the mandatory liquidation date. However, there can be no assurance that we will be able to consummate any business combination by February 5, 2023.

As of September 30, 2021, we had not commenced any operations. All activity for the period from February 24, 2021 (inception) through September 30, 2021 relates to our formation and the IPO. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after the completion of our initial Business Combination, at the earliest. We will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.18

~~For~~Risks ~~the~~and period from February 24, 2021 (inception) to September 30, 2021, we had a net loss of approximately $694, which consisted of formation costs. For the three months ended September 30, 2021, we had no net income or loss.Uncertainties

17Management is currently evaluating the impact of the COVID-19 pandemic and Russia-Ukraine war and has concluded that while it is reasonably possible that the virus and war could have a negative effect on our financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the accompanying unaudited condensed financial statements. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Contractual Obligations

We do not have any long-term ~~debt~~ ~~obligations~~debt, capital lease obligations, or operating lease obligations, ~~purchase~~other ~~obligations~~than orthe ~~long-term~~administrative ~~liabilities~~support agreement, registration rights and underwriters’ agreement as discussed below.

Administrative Support Agreement

~~Commencing on the date that~~We ~~our securities are first listed on the Nasdaq Global Market, we~~ agreed to pay ~~the~~an ~~Sponsor~~affiliate of our sponsor $10,000 per month for office space, utilities and secretarial and administrative support services. ~~Upon~~We ~~completion~~began incurring these fees on November 3, 2021 and will continue to incur these fees monthly until the earlier of the completion of the initial ~~Business~~business ~~Combination~~ combination or ~~our~~the Company’s liquidation. We incurred $30,000 wein ~~will~~administrative ~~cease~~support ~~paying~~service ~~these~~expense for ~~monthly~~the ~~fees~~three months ended March 31, 2022. At March 31, 2022 and December 31, 2021, a total of $10,000 has been accrued for amounts owed by us under the administrative support agreement.

Registration Rights

The holders of the ~~Founder~~founder ~~Shares~~shares, the ~~Private~~private ~~Placement~~placement ~~Warrants~~warrants (including securities contained therein) and warrants (including securities contained therein) that may be issued upon conversion of ~~Working~~working ~~Capital~~capital ~~Loans~~loans, and any shares of Class A common stock issuable upon the exercise of the ~~Private~~private ~~Placement~~placement ~~Warrants~~warrants and any shares of Class A common stock and warrants that may be issued upon conversion as part of the ~~Working~~working ~~Capital~~capital ~~Loans~~loans and Class A common stock issuable upon conversion of the ~~Founder~~founder ~~Shares~~shares, are entitled to registration rights pursuant to a registration rights agreement signed on November 5, 2021, requiring us to register such securities for resale (in the case of the ~~Founder~~founder ~~Shares~~shares, only after conversion to the Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial ~~Business~~business ~~Combination~~combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering our securities. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

OnThe underwriters ~~November~~are 5,entitled ~~2021,~~to ~~we paid~~ a ~~cash~~deferred underwriting discount of 23.05% ~~per~~of ~~Unit~~the gross proceeds of the initial public offering, or $47,~~025~~043,~~000~~750, which will be paid to the underwriters from the funds held in the trust account upon completion of our initial business combination, subject to the terms of the underwriting agreement.

The underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO, or $7,043,750, which will be paid to the underwriters from the funds held in the Trust Account upon completion of our initial Business Combination, subject to the terms of the underwriting agreement.19

~~Promissory~~Critical ~~Note~~Accounting Policies

OnCommon ~~March~~Stock ~~1, 2021, the Sponsor agreed~~ Subject to ~~loan~~Possible the Company up to $300,000 to be used for a portion of the expenses of the IPO. This loan is noninterest bearing, unsecured and is due at the earlier of December 31, 2021 or the closing of the IPO. As of September 30, 2021, the Company had borrowed $243,545 under the promissory note, which is currently due upon demand.Redemption

~~Critical~~We will ~~Accounting~~account ~~Policies~~for our common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our Class A common stock features certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, all shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of our balance sheet.

~~Deferred~~We recognize ~~Offering~~changes ~~Costs~~in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

~~We comply~~Net ~~with~~Loss ~~the~~Per ~~requirements of the ASC 340-10-S99-1. Deferred offering costs consists of legal, accounting, underwriting fees and other~~Common costs incurred through the balance sheet date that are directly related to the IPO. Offering costs are allocated to the separable financial instruments to be issued in the IPO based on a relative fair value basis, compared to total proceeds received. Upon closing of the IPO on November 5, 2021, offering costs associated with the Class A common stock and the warrants were charged to stockholders’ equity. Transaction costs amounted to $13,436,005, all of which was allocated to stockholders’ equity.Share

~~Common~~We comply ~~Stock~~with ~~Subject~~the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to ~~Possible~~forfeiture. ~~Redemption~~At March 31, 2022 and December 31, 2021, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted loss per share of common stock is the same as basic loss per share of common stock for the period presented.

We will account for our common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our Class A common stock features certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, all shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of our balance sheet.Warrants

18We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

WeFor issued ~~recognize~~or ~~changes~~modified inwarrants ~~redemption value~~that ~~immediately~~meet asall ~~they~~of ~~occur~~the ~~and~~criteria ~~adjusts~~for equity classification, the ~~carrying~~warrants ~~value~~are ofrequired ~~redeemable~~to ~~common~~be ~~stock~~recorded toas ~~equal~~a ~~the~~component of ~~redemption~~additional ~~value~~paid-in capital at the ~~end~~time of ~~each~~ ~~reporting period~~issuance. ~~Increases~~For issued or ~~decreases~~modified inwarrants ~~the~~that ~~carrying~~do ~~amount~~not meet all of ~~redeemable~~the ~~common~~criteria ~~stock~~for equity classification, the warrants are ~~affected~~required byto ~~charges~~be ~~against~~recorded ~~additional paid~~at intheir ~~capital~~initial fair value on the date of issuance, and ~~accumulated~~each ~~deficit~~balance sheet date thereafter. We account for our outstanding warrants as equity-classified instruments.

~~Net~~Recent ~~Loss Per Common Share~~Accounting Pronouncements

~~We comply~~The ~~with~~Company’s ~~the~~management does ~~accounting~~not ~~and~~believe ~~disclosure~~that ~~requirements~~any ofrecently ~~FASB ASC Topic 260~~issued, ~~“Earnings~~but ~~Per~~not ~~Share.” Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period~~effective, ~~excluding~~accounting ~~common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 656~~standards,~~250~~ ~~shares of common stock that are subject to forfeiture~~ if ~~the~~currently ~~over-allotment option is not exercised by the underwriter. At September 30~~adopted, ~~2021,~~would ~~we did not~~ have ~~any dilutive~~a ~~securities~~material ~~and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings~~effect ofon ~~us. As a result, diluted loss per common share is~~ the ~~same~~accompanying asfinancial ~~basic loss per common share for the period presented~~statements.

~~Warrants~~Off-Balance Sheet Arrangements

WeAs ~~account for warrants as either equity-classified or liability-classified instruments based on an assessment~~ of ~~the~~March ~~warrant’s specific terms and applicable authoritative guidance in FASB ASC 480~~31, ~~Distinguishing~~2022 ~~Liabilities from Equity (“ASC 480”)~~ and ~~ASC~~December ~~815~~31, ~~Derivatives~~ ~~and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480~~2021, ~~meet~~we ~~the~~did ~~definition~~not ofhave aany ~~liability~~off-balance ~~pursuant~~sheet to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classificationarrangements. ~~This assessment, which requires the use of professional judgment, is conducted at the time warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.~~

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. We account for our outstanding warrants as equity-classified instruments.20

~~Off-Balance~~Emerging ~~Sheet~~Growth ~~Arrangements~~Company Status

AsWe are an “emerging growth company,” as defined in Section 2(a) of ~~September~~the 30Securities Act, ~~2021~~as modified by the JOBS Act, and it may wetake ~~did~~advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not ~~have~~emerging growth ~~any~~companies ~~off~~including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-~~balance~~Oxley ~~sheet~~Act, ~~arrangements~~reduced asdisclosure ~~defined~~obligations regarding executive compensation in ~~Item~~our ~~303(~~periodic reports and proxy statements, and exemptions from the requirements of holding a~~)(4)(ii)~~ nonbinding advisory vote on executive compensation and stockholder approval of ~~Regulation~~any ~~S-K~~golden parachute payments not previously approved.

~~Inflation~~Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, us, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

WeFactors doThat ~~not~~May ~~believe that inflation~~Adversely ~~had~~Affect aOur ~~material~~Results ~~impact~~of ~~on our business, revenues or operating results during the period presented.~~Operations

~~Emerging~~Our results ~~Growth~~of ~~Company~~operations ~~Status~~and our ability to complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

WeITEM ~~are~~3. anQUANTITATIVE ~~“emerging growth~~AND ~~company,”~~QUALITATIVE asDISCLOSURES ~~defined~~ABOUT inMARKET Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.RISK

19We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

~~Further,~~ITEM Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards4. ~~The~~CONTROLS ~~JOBS Act~~AND provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocablePROCEDURES. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, us, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

~~Item~~Evaluation 3.of ~~Quantitative~~Disclosure Controls and ~~Qualitative Disclosures About Market Risk.~~Procedures

WeDisclosure controls and procedures are adesigned ~~smaller~~to ~~reporting~~ensure ~~company~~that asinformation ~~defined~~required byto ~~Rule~~be ~~12b-2~~disclosed ofby ~~the~~us in our Exchange Act reports is recorded, processed, summarized, and ~~are~~reported ~~not~~within ~~required~~the totime ~~provide~~periods specified in the SEC’s rules and forms, and that such information ~~otherwise~~is ~~required~~accumulated ~~under~~and ~~this~~communicated ~~item~~to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

~~Item~~Under the 4supervision and with the participation of our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. ~~Controls~~Based on this evaluation, our principal executive officer and ~~Procedures~~principal financial officer concluded that during the period covered by this report, our disclosure controls and procedures were effective.

~~Evaluation~~Changes ofin ~~Disclosure~~Internal ~~Controls~~Control ~~and~~over ~~Procedures~~Financial Reporting

~~Disclosure~~There ~~controls~~were ~~and~~no ~~procedures~~changes ~~are~~in ~~designed~~our tointernal ~~ensure~~control ~~that~~over ~~information~~financial ~~required~~reporting to(as besuch ~~disclosed~~term byis usdefined in ~~our~~Rules ~~Exchange~~13a-15(f) ~~Act reports is recorded, processed, summarized,~~ and ~~reported~~15d-15(f) ~~within~~of the ~~time~~Exchange Act) ~~periods~~during ~~specified in~~ the ~~SEC’s~~most ~~rules~~recent ~~and~~fiscal ~~forms,~~quarter ~~and~~ that ~~such~~have ~~information~~materially ~~is accumulated and communicated to our management~~affected, ~~including our principal executive officer and principal financial officer~~ or ~~persons~~are ~~performing similar~~reasonably ~~functions,~~likely ~~as appropriate~~ to ~~allow~~materially ~~timely~~affect, ~~decisions~~our ~~regarding~~internal control ~~required~~over ~~disclosure~~financial reporting.

Under the supervision and with the participation of our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that during the period covered by this report, our disclosure controls and procedures were effective.21

~~Changes~~PART ~~in Internal~~II—OTHER ~~Control over Financial Reporting~~INFORMATION

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2021 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

~~Risk~~Factors ~~factors~~ that could cause our actual results to differ materially from those in this ~~report~~Quarterly ~~include~~Report ~~the~~on ~~risk~~Form ~~factors~~10-Q are any of the risks described in our ~~final~~Annual ~~prospectus~~Report on ~~for~~Form ~~the~~10-K ~~Public Offering~~ filed with the SEC. Ason ~~of the~~April ~~date~~15, of2022. ~~this~~Except ~~report~~as disclosed, below, there have been no material changes to the risk factors disclosed in our ~~final~~Annual ~~prospectus~~Report on Form 10-K for the ~~Public~~period ~~Offering filed~~ended ~~with~~December ~~the~~31, ~~SEC~~2021.

Changes in laws or regulations or how such laws or regulations are interpreted or applied, or a failure to comply with any laws or regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.

We are subject to laws and regulations enacted by national, regional and local governments. We will be required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business combination and results of operations.

On March 30, 2022, the SEC issued proposed rules relating to, among other items, disclosures in business combination transactions involving SPACs and private operating companies; the financial statement requirements applicable to transactions involving shell companies; the use of projections in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and the extent to which special purpose acquisition companies (“SPACs”) could become subject to regulation under the Investment Company Act of 1940, as amended, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC’s duration, asset composition, business purpose and activities. These rules, if adopted, whether in the form proposed or in a revised form, may increase the costs of and the time needed to negotiate and complete an initial business combination, and may constrain the circumstances under which we could complete an initial business combination.

Military conflict in Ukraine could make it more difficult for us to consummate a business combination.

Military conflict in Ukraine may lead to increased and price volatility for publicly traded securities, including ours, and to other national, regional and international economic disruptions and economic uncertainty, any of which could make it more difficult for us to identify a business combination partner and consummate a business combination on acceptable commercial terms or at all.

Recent increases in inflation in the United States and elsewhere could make it more difficult for us to consummate a business combination.

Recent increases in inflation in the United States and elsewhere may be leading to increased price volatility for publicly traded securities, including ours, and may lead to other national, regional and international economic disruptions, any of which could make it more difficult for us to consummate a business combination.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

~~Unregistered Sales of Equity Securities~~None

OnItem ~~March 9, 2021, the Sponsor purchased 8,625,000 Founder Shares for an aggregate purchase price of $25,000, or approximately $0~~3.~~003~~ ~~per~~Defaults ~~share. Such~~upon ~~shares~~Senior ~~were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the~~ Securities ~~Act~~. On June 23, 2021, the Sponsor returned to the Company, at no cost, an aggregate of 2,875,000 Founder Shares, which the Company cancelled. On October 1, 2021, the Sponsor returned to the Company, at no cost, an aggregate of 718,750 Founder Shares, which the Company cancelled, resulting in an aggregate of 5,031,250 Founder Shares outstanding and held by the Sponsor, or approximately $0.005 per share. Up to 656,250 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. As a result of the full exercise of the over-allotment option by the underwriters upon the consummation of the IPO, these shares are no longer subject to forfeiture.

On November 5, 2021, the Sponsor cancelled 300,000 Founder Shares at no cost, and the representative purchased 300,000 Class B shares, for an aggregate purchase price of $1,000,000, in connection with the closing of the IPONone. ~~Such shares were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.~~

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 9,050,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $9,050,000. Such warrants were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Use of Proceeds

Of the gross proceeds received from the IPO, including the full exercise of the over-allotment option, and the sale of the Private Placement Warrants, $205,275,000 ($10.20 per Unit) was placed in the Trust Account.

Transaction costs amounted to $13,436,005 consisting of $4,025,000 of underwriting commissions, $7,043,750 of deferred underwriting fees, $1,847,600 of fair value of the Representative Shares in excess of cash paid, and $519,655 of other offering costs, and was all charged to stockholders’ deficit.

There has been no material change in the planned use of the proceeds from the IPO and the sale of the Private Placement Warrants as is described in the final prospectus included in the Registration Statement.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not ~~Applicable~~applicable.

Item 5. Other Information.

None.

~~Item 6. Exhibits~~22

~~The~~Item ~~following~~6. ~~exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q~~Exhibits.

Exhibit Number		Description
31.1		Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).*
31.1*		Certification of Co-Chief Executive Officers (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).*
31.2*		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of the Principal Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350.**
32.1**		Certification of Co-Chief Executive Officers (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification of the Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350.**
32.2**		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		Inline XBRL Instance Document.*
101.INS*		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document.*
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*
104*		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

*	Filed herewith.
**	Furnished.

2223

SIGNATURES

InPursuant to ~~accordance with~~ the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this ~~report~~Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	McLaren Technology Acquisition Corp.
	MCLAREN TECHNOLOGY ACQUISITION CORP.
December 17, 2021	By:	/s/ Sajan Pillai
May 16, 2022	By:	/s/ Sajan Pillai
	Name:	Sajan Pillai
	Title:	Chief Executive Officer (Principal Executive Officer)
May 16, 2022	By:	/s/ Rajeev Nair
	Name:	Rajeev Nair
	Title:	Chief Financial Officer (Principal Accounting and Financial Officer)

2324

Filing Compare · McLaren Technology Acquisition Corp.